Moderna Inc said on Wednesday that an analysis of the early-stage data of its experimental COVID-19 vaccine showed it induced immune responses in older adults that were similar to younger participants...
The United States has penned an agreement with drugmaker Moderna Inc to acquire 100 million doses of its potential COVID-19 vaccine, U.S. President Donald Trump said on Tuesday.